LUIS VERA: Open Payments
NPI 1649632670 · NORWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 42 payments from 7 companies in 2025. Trend: 2023 $17 · 2024 $321 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 15 | $228 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $136 |
| E.R. Squibb & Sons, L.L.C. | 2 | $95 |
| Alkermes, Inc. | 4 | $79 |
| Corium, LLC | 2 | $38 |
| Lundbeck LLC | 1 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
Products named: INGREZZA, CAPLYTA, COBENFY, ARISTADA, Azstarys, REXULTI, FANAPT.
Industry payments across CT — which companies pay providers there.
